Genomics Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
170
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$44M
- Investors
-
16
Genomics General Information
Description
Developer of a genetic inference technology designed to lead the genomic transformation by finding new drug targets for serious diseases. The company uses an analytical platform for genomic sequence data investigation and consultancy which maximizes the impact of DNA sequencing and helps to identify individuals at risk of particular diseases, enabling pharmaceutical businesses to avail a genomic engine that de-risks the drug development process and provides improved healthcare.
Contact Information
Website
www.genomics.comCorporate Office
- King Charles House
- Park End Street
- Oxford OX1 1JD
- England, United Kingdom
Corporate Office
- King Charles House
- Park End Street
- Oxford OX1 1JD
- England, United Kingdom
Genomics Timeline
Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series C) | 08-Nov-2024 | $44M | Completed | Generating Revenue | ||
| 6. Later Stage VC | 12-Oct-2021 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series B) | 30-Aug-2018 | Completed | Generating Revenue | |||
| 4. Grant | 12-Mar-2015 | Completed | Startup | |||
| 3. Early Stage VC (Series A) | 26-Nov-2014 | Completed | Startup | |||
| 2. Early Stage VC | 30-Jul-2014 | $1.9M | $1.9M | Completed | Startup | |
| 1. University Spin-Out | 10-Jan-2014 | Completed | Startup |
Genomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Ordinary | ||||||||
| G Ordinary | ||||||||
| Ordinary | ||||||||
| G Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 78,800 | $0.012994 | $1.73 | $1.73 | 1x | $1.73 | 0.42% | |
| Ordinary | 1,507,500 | $0.012994 | $0.87 | $0.87 | 1x | $0.87 | 7.97% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Genomics Comparisons
Industry
Financing
Details
Genomics Competitors (38)
One of Genomics’s 38 competitors is Genomenon, a Venture Capital-Backed company based in Ann Arbor, MI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genomenon | Venture Capital-Backed | Ann Arbor, MI | ||||
| DNAnexus | Venture Capital-Backed | Mountain View, CA | ||||
| Second Genome | Formerly VC-backed | Brisbane, CA | ||||
| Oxford Nanopore Technologies | Formerly VC-backed | Oxford, United Kingdom | ||||
| Nebula Genomics | Venture Capital-Backed | Garden City, NY |
Genomics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Genomics Patents
Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202114554-D0 | Computer-implemented method and apparatus for analysing genetic data | Inactive | 12-Oct-2021 | ||
| EP-4200856-B1 | Computer-implemented method and apparatus for analysing genetic data | Active | 12-Oct-2021 | ||
| EP-4200856-A1 | Computer-implemented method and apparatus for analysing genetic data | Active | 12-Oct-2021 | ||
| ES-2964691-T3 | Method implemented by computer and device to analyze genetic data | Active | 12-Oct-2021 | ||
| CA-3234482-A1 | Computer-implemented method and apparatus for analysing genetic data | Pending | 12-Oct-2021 | G16B20/20 |
Genomics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Genomics Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Infinity Capital Partners | Hedge Fund | Minority | ||
| Eight Roads | Corporate Venture Capital | Minority | ||
| Salica Investments | Venture Capital | Minority | ||
| Foresite Capital | Growth/Expansion | Minority | ||
| F-Prime Capital | Venture Capital | Minority |
Genomics FAQs
-
When was Genomics founded?
Genomics was founded in 2014.
-
Where is Genomics headquartered?
Genomics is headquartered in Oxford, United Kingdom.
-
What is the size of Genomics?
Genomics has 170 total employees.
-
What industry is Genomics in?
Genomics’s primary industry is Discovery Tools (Healthcare).
-
Is Genomics a private or public company?
Genomics is a Private company.
-
What is the current valuation of Genomics?
The current valuation of Genomics is .
-
What is Genomics’s current revenue?
The current revenue for Genomics is .
-
How much funding has Genomics raised over time?
Genomics has raised $142M.
-
Who are Genomics’s investors?
Infinity Capital Partners, Eight Roads, Salica Investments, Foresite Capital, and F-Prime Capital are 5 of 16 investors who have invested in Genomics.
-
Who are Genomics’s competitors?
Genomenon, DNAnexus, Second Genome, Oxford Nanopore Technologies, and Nebula Genomics are some of the 38 competitors of Genomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
